Storia in 4 fonti

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

Raccontata da

forbes.com

morningstar.com

endpoints.news

benzinga.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo1 g fa

Abbisko Therapeutics Deepens R&D Collaboration with Lilly

originale

benzinga.com11 h fa

Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact - Eli Lilly (NYSE:LLY)

Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.

Leggi questa versione → originale

forbes.com1 g fa

Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration

Strategic research collaboration and license agreement is worth up to $1.9 billion to Abbisko

Leggi questa versione → originale

endpoints.news16 h fa

Lilly offers up to $1.9B in new drug discovery deal with Abbisko

Building on a pact from 2022, Eli Lilly has signed a new discovery collaboration with Abbisko Therapeutics that could see it pay the Chinese biotech up to $1.9 billion.

Leggi questa versione → originale

Timeline cronologica

mercoledì 24 giugno 2026·forbes.com
Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration
Strategic research collaboration and license agreement is worth up to $1.9 billion to Abbisko
mercoledì 24 giugno 2026·morningstar.com
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
mercoledì 24 giugno 2026·endpoints.news
Lilly offers up to $1.9B in new drug discovery deal with Abbisko
Building on a pact from 2022, Eli Lilly has signed a new discovery collaboration with Abbisko Therapeutics that could see it pay the Chinese biotech up to $1.9 billion.
mercoledì 24 giugno 2026·benzinga.com
Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact - Eli Lilly (NYSE:LLY)
Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.